The 'Oreo test' and other ways to help kids' oral health (HealthDay)—Worried your kid isn't brushing their teeth properly? You might want to try the Oreo test. Feb 1, 2022 0 30
Long-acting cabotegravir not necessarily cost-effective for PrEP (HealthDay)—For men who have sex with men and transgender women (MSM/TGW) at very high risk for HIV (VHR), the benefits of long-acting injectable cabotegravir (CAB-LA) in terms of life expectancy do not necessarily justify ... Feb 1, 2022 0 3
Response to exercise is key to novel device therapy for the most common type of heart failure Heart failure with preserved ejection fraction (HFpEF), also called diastolic heart failure, affects 3 million Americans. Despite being the most common type of heart failure in the United States, effective treatments remain ... Feb 1, 2022 0 34
Study identifies seven factors that increase mortality risk for patients with COVID-19 The risk of death for patients with SARS-CoV-2 infection and thoracic cancer is based on seven major determinants, according to research published in the Journal of Thoracic Oncology, the official journal of the International ... Feb 1, 2022 0 7
Treatment keeps alcoholic monkeys from drinking as much A hormone produced by the liver called fibroblast growth factor 21 (FGF21) suppresses alcohol consumption in primates, finds a study published February 1 in the journal Cell Metabolism. Vervet monkeys with a strong preference ... Feb 1, 2022 0 109
Study finds racial and ethnic disparities in COVID-19 vaccine uptake People from racial and ethnic minorities in the United States and the United Kingdom were up to three times as likely to report being unsure or unwilling to get a COVID-19 vaccine during the initial vaccine rollout compared ... Feb 1, 2022 0 5
Promising results of Phase 1 drug trial for HIV patients A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ... Feb 1, 2022 0 65
Genomics study helps guide shigella vaccine development A new genomics study led by the University of Liverpool will help guide the development and use of vaccines against a globally leading cause of severe diarrhea in children: shigella. Feb 1, 2022 0 40
Experts share tips for reducing dementia risk Dementia and memory loss do not have to be part of aging. Good habits can help stave off damage to our brains, according to a new study from a risk reduction work group of nine clinicians and health researchers convened by ... Feb 1, 2022 0 9
Wnt signaling is identified as a target in NEDAMSS disorder in children A recent study conducted by researchers at Baylor College of Medicine and Texas Children's Hospital is the first to identify an underlying mechanism and possible drug targets for a new severe neurological disorder in children ... Feb 1, 2022 0 16
